case_images: PMC11041960_01
case_images: Chest CT and abdominal MRI showed left lung and multiple liver masses (A-D). (white arrow indicate lung and liver masses).
case_images: HMER-16-31-g0001.jpg
case_images: PMC11041960_01_HMER-16-31-g0001.jpg
case_images: f0001
case_images: After being admitted to our hospital, chest computed tomography (CT) and abdominal magnetic resonance imaging (MRI) was performed to assess the tumor, revealing the presence of mass in the left lung and multiple masses in the liver (Figure 1), brain MRI and bone scintigraphy showed no brain or bone metastases.
case_images: Pathological findings of liver mass in segment VII-VIII. Hematoxylin and eosin (H&E) staining. Original magnification: (A)x40. (B) x100.
case_images: HMER-16-31-g0002.jpg
case_images: PMC11041960_01_HMER-16-31-g0002.jpg
case_images: f0002
case_images: Pathological findings of liver mass in segment V. Hematoxylin and eosin (H&E) staining. Original magnification: (A)x40. (B) x100.
case_images: HMER-16-31-g0003.jpg
case_images: PMC11041960_01_HMER-16-31-g0003.jpg
case_images: f0003
case_images: Consequently, a puncture biopsy of the mass in liver segment V was conducted, yielding findings consistent with hepatocellular carcinoma (Figure 3), Immunohistochemistry results were as follows: GS(+), GPC3 (focal +), HSP70 (focal +), CD34 (+), CK19 (-), Arginase-1 (+), HepPar-1 (+), AFP (-), Ki-67 (active zone about 15%+).
case_images: Chest CT images before and after treatment. The time of CT was (A) 2022-07-25, (B) 2022-09-14, (C) 2023-02-08, (D) 2023-06-28. (white arrow indicate lung mass).
case_images: HMER-16-31-g0004.jpg
case_images: PMC11041960_01_HMER-16-31-g0004.jpg
case_images: f0004
case_images: Three months after the treatment, imaging studies revealed stable tumors in chest, head and liver was stable (Figures 4-6), but an enlargement of retroperitoneal lymph nodes and enhanced margins of a liver mass in the V segment.
case_images: Abdominal MRI and CT images before and after treatment. The time of MRI was (Ai-Aii) 2022-07-25, the time of CT was (Bi-Bii) 2022-09-14, (Ci-Cii) 2022-10-17, (Di-Dii) 2023-02-08, (Ei-Eii) 2023-06-28. (white arrow indicate liver masses).
case_images: HMER-16-31-g0005.jpg
case_images: PMC11041960_01_HMER-16-31-g0005.jpg
case_images: f0005
case_images: Three months after the treatment, imaging studies revealed stable tumors in chest, head and liver was stable (Figures 4-6), but an enlargement of retroperitoneal lymph nodes and enhanced margins of a liver mass in the V segment.
case_images: Brain MRI images before and after treatment. The time of MRI was (A) 2022-06-24, (B) 2022-10-24, (C) 2023-02-09, (D) 2023-05-11. (white arrow indicate brain mass in the left parietal lobe).
case_images: HMER-16-31-g0006.jpg
case_images: PMC11041960_01_HMER-16-31-g0006.jpg
case_images: f0006
case_images: Three months after the treatment, imaging studies revealed stable tumors in chest, head and liver was stable (Figures 4-6), but an enlargement of retroperitoneal lymph nodes and enhanced margins of a liver mass in the V segment.